Senior Associate Scientist
Alector
Senior Associate Scientist
Alector
Biopharmaceutical R&D for neurodegenerative therapies
Salary Range: 125000 to 140000 (Currency: USD) (Pay period: per-year-salary)
We are seeking a Senior Associate Scientist, Bioanalytical Sciences to support bioanalytical assay development and execution across Alector’s nonclinical and clinical programs. You will be a hands-on laboratory scientist responsible for independently developing, optimizing, troubleshooting, and qualifying bioanalytical assays while also managing selected activities performed at external CROs.
You will bring strong experience with ligand-binding assays for pharmacokinetic, immunogenicity and biomarker assessments, including independent, hands-on development of PK, anti-drug antibody (ADA) and/or biomarker assays in biological samples such as CSF, serum/plasma, and tissue lysates. You must also have direct bioanalytical experience supporting a range of therapeutic modalities, such as antibodies, bispecific antibodies, and/or conjugated siRNA/ASOs.
This is an individual-contributor position with no people-management responsibilities. You will work closely with colleagues across Research, Toxicology, Clinical Development, and external partners to generate high-quality bioanalytical data that supports program decisions.
You will partner closely with colleagues across Research, Toxicology, Clinical Development, and other multidisciplinary teams. We expect you to communicate experimental results, assay limitations, risks, and recommendations clearly. We share knowledge openly, solve problems together, and adapt quickly as program needs evolve.
Alector is a biopharmaceutical company that develops therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's. It uses insights from immunology, neurology, and human genetics to create medicines that help the body heal itself. The company focuses on researching and developing novel therapeutic candidates, mainly through early-stage clinical trials to quickly gather disease-specific data and improve the chances of success. Revenue and funding come from partnerships, grants, and eventual product commercialization. Alector aims to advance treatments for unmet medical needs in neurodegenerative diseases by pursuing a pipeline that combines scientific findings with strategic drug development.
Explore more opportunities at Alector